Teleflex Incorporated (T1FX34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 15 Oct 2026
Key indicators
| Last close | BRL 62.04 |
|---|---|
| 52-week range | 52.35 – 74.57 |
| Return, 1 month / 3 months | −11.1% / −10.9% |
| Return, 1 year / 3 years | −6.3% / −52.5% |
| Trend | Below its 200-day average |
| RSI (14) | 11 |
| Volatility (1 year) | 40.2% |
| Worst drawdown (1 year) | -28.4% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Teleflex Incorporated is a medical technology company that designs and makes devices used in critical care, surgery, urology, anesthesia and vascular access, including catheters, needles and related instruments. Its customers are hospitals, clinicians and healthcare providers, and it also supplies specialized products to aerospace and industrial customers. The company is based in the United States and serves markets around the world.
Teleflex Incorporated is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code T1FX34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Teleflex Incorporated (T1FX34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 62.04 on 15 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 1,020 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.3% and over the last three months it fell 10.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.7% | ||
| From 52-week high | -16.8% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.9% | ||
| 6-month return | -8.1% | ||
| 12-month return, skipping the last month | 5.4% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.4% | ||
| Liquidity | 3 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 93.3% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | −11.1% |
| 3 months | −10.9% |
| 6 months | −8.1% |
| 1 year | −6.3% |
| 3 years | −52.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 68.74 / 64.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | USD 0.1243 |
| 22 May 2026 | USD 0.1236 |
| 5 Mar 2026 | USD 0.1226 |
| 13 Nov 2025 | USD 0.1297 |
| 14 Aug 2025 | USD 0.1264 |
| 19 May 2025 | USD 0.1303 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.